$1.86
3.63% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
KYG9442G1047
Symbol
UPC
Sector
Industry

Universe Pharmaceuticals INC Stock price

$1.86
-3.21 63.31% 1M
-34.14 94.83% 6M
-28.29 93.83% YTD
-11.64 86.22% 1Y
-203.34 99.09% 3Y
-425.64 99.56% 5Y
-425.64 99.56% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.07 3.63%
ISIN
KYG9442G1047
Symbol
UPC
Sector
Industry

Key metrics

Market capitalization $2.93m
Enterprise Value $-1.95m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.32
EV/Sales (TTM) EV/Sales -0.07
P/S ratio (TTM) P/S ratio 0.11
P/B ratio (TTM) P/B ratio 0.25
Revenue growth (TTM) Revenue growth -22.33%
Revenue (TTM) Revenue $26.73m
EBIT (operating result TTM) EBIT $-5.42m
Free Cash Flow (TTM) Free Cash Flow $-6.18m
EPS (TTM) EPS $-5.10
Short interest 1.31%
Show more

Is Universe Pharmaceuticals INC a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Financial data from Universe Pharmaceuticals INC

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Mar '24
+/-
%
27 27
22% 22%
100%
- Direct Costs 19 19
5% 5%
73%
7.31 7.31
48% 48%
27%
- Selling and Administrative Expenses 9.58 9.58
31% 31%
36%
- Research and Development Expense 2.65 2.65
73% 73%
10%
-4.92 -4.92
48% 48%
-18%
- Depreciation and Amortization 0.50 0.50
0% 0%
2%
EBIT (Operating Income) EBIT -5.42 -5.42
46% 46%
-20%
Net Profit -19 -19
66% 66%
-69%

In millions USD.

Don't miss a Thing! We will send you all news about Universe Pharmaceuticals INC directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Universe Pharmaceuticals INC Stock News

Neutral
GlobeNewsWire
25 days ago
Ji'an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on October 25, 2024, notifying the Company that it is not in compliance with the minimum bi...
Neutral
GlobeNewsWire
2 months ago
JI'AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2024 ended March 31, 2024.

Company Profile

Universe Pharmaceuticals, Inc. manufactures, markets, and distributes traditional derivative products. It also sells biomedical drugs, medical instruments, traditional and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on December 12, 1998 and is headquartered in Ji'an, China.

Head office Cayman Islands
CEO Gang Lai
Employees 225
Founded 1998
Website www.universe-pharmacy.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today